Recent clinical development of minimally invasive closure for atrial septal defect
- VernacularTitle:微创封堵治疗房间隔缺损的临床进展
- Author:
Qi ZHOU
1
,
2
;
Yu HAN
3
;
Shubo SONG
1
,
2
;
Taibing FAN
1
,
2
;
Xiangbin PAN
4
Author Information
1. Department of Cardiac Surgery, Zhengzhou University People'
2. s Hospital, Zhengzhou, 450003, P.R.China
3. Department of Structural Heart Disease, Fuwai Central China Cardiovascular Hospital, Zhengzhou, 450003, P.R.China
4. Department of Structural Heart Disease, Fuwai Hospital, Chinese Academy of Medical Science, Beijing, 100037, P.R.China
- Publication Type:Journal Article
- Keywords:
Atrial septal defect;
occluder;
minimally invasive occlusion;
echocardiography guidance;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(12):1508-1512
- CountryChina
- Language:Chinese
-
Abstract:
Atrial septal defect (ASD) is a congenital heart disease that causes blood communication between the left and right ventricles due to partial atrial septal tissue defects, accounting for about 13% of all heart malformations. Secondary ASD is the most common type of ASD and can generally be treated with minimally invasive closure. At present, the commonly used minimally invasive methods in clinical practice mainly include X-ray-guided percutaneous occlusion, transesophageal ultrasound-guided transthoracic occlusion and ultrasound-guided percutaneous occlusion. This review focuses on the basic research process of occluder materials, and advantages and disadvantages of three different surgical methods.
